PLG and cancer: The goal of these studies was to selectively release the drugs in the tumor microenvironment, exploiting the secreted cathepsin B form, which associates to the plasminogen cascade, the latter leading to the activation of factors involved in the extracellular matrix degradation and cancer cells invasion.